Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3515e1e6a5ac978f5eed4edbeb73a8a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00817 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00844 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00891 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2009-00897 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B90-361 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-008 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00821 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0613 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00823 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B90-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-067 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06 |
filingDate |
2018-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b932d325bc2bf8005ab81b84522f4c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e71e7832c2088684acf9bfa27db7b9f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6062540d71fbf01a90336553f7984ef2 |
publicationDate |
2018-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2018280196-A1 |
titleOfInvention |
System for neuroprotective therapy for glaucoma |
abstract |
Providing neuroprotective therapy for glaucoma includes generating a micropulsed laser light beam having parameters and characteristics, including pulse length, power, and duty cycle, selected to create a therapeutic effect with no visible laser lesions or tissue damage to the retina. The laser light beam is applied to retinal and/or foveal tissue of an eye having glaucoma or a risk of glaucoma to create a therapeutic effect to the retinal and/or foveal tissue exposed to the laser light beam without destroying or permanently damaging the retinal and/or foveal tissue and improve function or condition of an optic nerve and/or retinal ganglion cells of the eye. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11737665-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020123868-A1 |
priorityDate |
2012-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |